oxaliplatin,docetaxel,bevacizumab
roche
['oxaliplatin', 'bevacizumab', 'ovarian', 'docetaxel']
hot off the presses! ovarian cancer guidelines endorse oxaliplatin-based regimens like docetaxel/oxali/bevacizumab (teaco trial) in special circumstances (i.e. chemo shortages ). thank u dr. deb armstrong &amp; team for supporting the recs. 
GYN oncologist at Johns Hopkins.  Endometrial and rare GYN cancer researcher. Wife, mother, daughter, sister. Tweets are my own. She/hers.